BROOKE KLING: Open Payments
NPI 1912784943 · HARTVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 23 payments from 11 companies in 2025. Trend: 2023 $164 · 2024 $461 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $121 |
| Lilly USA, LLC | 5 | $82 |
| Organon LLC | 3 | $68 |
| Amgen Inc. | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $33 |
| Novo Nordisk Inc | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Ascensia Diabetes Care Us Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: DEXCOM G7 GSS (161), JARDIANCE, NEXPLANON, REPATHA, Auvelity, Veozah, Ozempic, SPRAVATO.
Industry payments across OH — which companies pay providers there.
